Bankrupt antibiotics maker Aradigm turns to old partner/investor for final $3M fire sale

Bankrupt antibiotics maker Aradigm turns to old partner/investor for final $3M fire sale

Source: 
Endpoints
snippet: 

Grifols once paid Aradigm $26 million for a stake in its inhaled antibiotics. But with Aradigm now in bankruptcy, the Spanish drugmaker is dishing out a final $3.2 million to buy it all.